Vedanta Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 9

Professionals

  • Investments
  • 44

  • Portfolio
  • 7

  • Exits
  • 29

Exits

Vedanta Capital General Information

Company Description

Founded in 2006, Vedanta Capital is a venture capital firm based in New York. The firm seeks to invest in B2C, healthcare, information technology, foodtech, SaaS, TMT, lifesciences, pet technology, retail and beauty sectors.

Business Details

Website
www.vedacap.com
Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Fund of Funds
Growth/Expansion
PE/Buyout
Corporate Office
  • 250 West 55th Street
  • Suite 16C
  • New York, NY 10019
  • United States
+1 (212)

Vedanta Capital Investments (44)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Bicara Therapeutics 06-Dec-2023 Later Stage VC Drug Discovery Generating Revenue
Bicara Therapeutics 08-Sep-2023 Drug Discovery Generating Revenue
Immuneel 11-Apr-2022 Drug Discovery Clinical Trials - General
TauC3 Biologics 31-Mar-2022 Drug Discovery Pre-Clinical Trials
Eruditus Executive Education 31-Aug-2020 Education and Training Services (B2B) Profitable
Immuneel 10-Aug-2020 Drug Discovery Clinical Trials - General
Volterra. 07-Nov-2019 Systems and Information Management Generating Revenue
SetuServ 04-Oct-2018 Business/Productivity Software Generating Revenue
Oncternal Therapeutics 15-Dec-2017 Early Stage VC Drug Discovery Generating Revenue
Breathe Technologies 29-Mar-2017 Later Stage VC Therapeutic Devices Profitable
You’re viewing 10 of 44 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vedanta Capital Exits (29)

Company Name Exit Date Exit Type Exit Size
d2i 07-Apr-2026 Buyout/LBO
Bicara Therapeutics 13-Sep-2024
Chelsio Communications 01-May-2023
Volterra. 22-Jan-2021
Augere 01-Oct-2019
Breathe Technologies 03-Sep-2019
Oncternal Therapeutics 07-Jun-2019
Callidus Software 05-Apr-2018
Azoi 01-Nov-2017 Out of Business
Genband 27-Oct-2017 Merger/Acquisition
You’re viewing 10 of 29 exits. Get the full list »

Vedanta Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Vedanta Capital‘s full profile, request access.

Request a free trial

Vedanta Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Vedanta Capital Co-Investors (30)

Name With Exits Lead Partner Series Industry
Eight Roads 2 Series chart Industry bar
F-Prime Series chart Industry bar
Fairmount Partners Series chart Industry bar
Piper Sandler Series chart Industry bar
TPG Series chart Industry bar
You’re viewing 5 of 30 co-investors. Get the full list »

Vedanta Capital FAQs

  • What is Vedanta Capital?

    Founded in 2006, Vedanta Capital is a venture capital firm based in New York.

  • When was Vedanta Capital founded?

    Vedanta Capital was founded in 2006.

  • Where is Vedanta Capital headquartered?

    Vedanta Capital is headquartered in New York, NY.

  • What is Vedanta Capital's total asset value?

    Vedanta Capital has around in total assets under management.

  • How many investments has Vedanta Capital made?

    Vedanta Capital has made 44 investments.

  • What has Vedanta Capital invested in?

    Vedanta Capital has made numerous investments in companies like Bicara Therapeutics, Immuneel, and TauC3 Biologics within the Drug Discovery industry.

  • What has Vedanta Capital invested in recently?

    Vedanta Capital's latest investment was on 06-Dec-2023 in Bicara Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process